Bank of Montreal vs Bristol-Myers Squibb Company
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Bank of Montreal
$131.4B
μμ #130
Bristol-Myers Squibb Company
$132.0B
μμ #127
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ°λλ³ λΉκ΅
| μ°λ | Bank of Montreal | Bristol-Myers Squibb Company | μ λ |
|---|---|---|---|
| 2026 | $131.4B | $132.0B | Bristol-Myers Squibb Company |
| 2025 | $89.6B | $107.8B | Bristol-Myers Squibb Company |
| 2024 | $67.2B | $107.6B | Bristol-Myers Squibb Company |
| 2023 | $60.2B | $92.9B | Bristol-Myers Squibb Company |
| 2022 | $53.6B | $125.8B | Bristol-Myers Squibb Company |
| 2021 | $57.2B | $105.8B | Bristol-Myers Squibb Company |
| 2020 | $39.2B | $102.0B | Bristol-Myers Squibb Company |
| 2019 | $38.7B | $102.4B | Bristol-Myers Squibb Company |
| 2018 | $32.9B | $80.2B | Bristol-Myers Squibb Company |
| 2017 | $35.8B | $92.0B | Bristol-Myers Squibb Company |
| 2016 | $33.1B | $85.4B | Bristol-Myers Squibb Company |
| 2015 | $25.7B | $98.2B | Bristol-Myers Squibb Company |
| 2014 | $25.9B | $82.3B | Bristol-Myers Squibb Company |
| 2013 | $21.4B | $72.0B | Bristol-Myers Squibb Company |
| 2012 | $17.6B | $42.7B | Bristol-Myers Squibb Company |
| 2011 | $15.4B | $44.4B | Bristol-Myers Squibb Company |
| 2010 | $15.2B | $31.8B | Bristol-Myers Squibb Company |
| 2009 | $14.1B | $28.9B | Bristol-Myers Squibb Company |
| 2008 | $7.4B | $25.1B | Bristol-Myers Squibb Company |
| 2007 | $12.5B | $27.1B | Bristol-Myers Squibb Company |
| 2006 | $14.7B | $25.9B | Bristol-Myers Squibb Company |
| 2005 | $13.4B | $21.6B | Bristol-Myers Squibb Company |
| 2004 | $11.5B | $23.0B | Bristol-Myers Squibb Company |
| 2003 | $10.4B | $24.5B | Bristol-Myers Squibb Company |
| 2002 | $7.9B | $19.0B | Bristol-Myers Squibb Company |
| 2001 | $6.5B | $40.3B | Bristol-Myers Squibb Company |
| 2000 | $7.0B | $54.6B | Bristol-Myers Squibb Company |
| 1999 | $4.2B | $46.6B | Bristol-Myers Squibb Company |
| 1998 | $5.1B | $48.0B | Bristol-Myers Squibb Company |
| 1997 | $5.1B | $33.4B | Bristol-Myers Squibb Company |
| 1996 | $3.4B | $18.8B | Bristol-Myers Squibb Company |
| 1995 | $2.4B | $14.3B | Bristol-Myers Squibb Company |